Systemic, local, and imaging biomarkers of brain injury: More needed, and better use of those already established?

Frontiers in Neurology

Volumn 6, Issue FEB, 2015, Pages

  Carpenter, Keri L H ^a   Czosnyka, Marek ^a   Jalloh, Ibrahim ^a   Newcombe, Virginia F J ^a   Helmy, Adel ^a   Shannon, Richard J ^a   Budohoski, Karol P ^a   Kolias, Angelos G ^a   Kirkpatrick, Peter J ^a   Carpenter, Thomas Adrian ^a   Menon, David K ^a   Hutchinson, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Acute brain injury (human); Biomarkers; Blood brain barrier; Cell death; Cerebral energy metabolism; Imaging; Inflammation; Multimodality monitoring

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; BIOLOGICAL MARKER; BRAIN PROTEIN; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROL; INOSITOL; INTERLEUKIN 8; LACTIC ACID; N ACETYLASPARTIC ACID; OXYGEN; PHOSPHATE; PROTEIN S100B; PYRUVIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL PRESSURE; ARTICLE; BLOOD ANALYSIS; BRAIN INJURY; BRAIN METABOLISM; BRAIN OXYGEN TENSION; BRAIN PERFUSION; BRAIN SURGERY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; EMERGENCY CARE; EXPERIMENTAL MODEL; HOSPITAL CARE; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROGNOSIS; QUANTITATIVE ANALYSIS; REHABILITATION CARE; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TRAUMATIC BRAIN INJURY;

EID: 84926479518     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00026     Document Type: Article

References (200)

1. Kolias AG, Guilfoyle MR, Helmy A, Allanson J, Hutchinson PJ. Traumatic brain injury in adults. Pract Neurol (2013) 13(4):228-35. doi:10.1136/practneurol-2012-000268
2. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma (2007) 24(Suppl 1):S1-106. doi:10.1089/neu.2007.9999
3. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol (2008) 7(8):728-41. doi:10.1016/S1474-4422(08)70164-9
4. Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol (2013) 9(4):231-6. doi:10.1038/nrneurol.2013.22
5. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med (2006) 354(4):387-96. doi:10.1056/NEJMra052732
6. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain (2001) 124(Pt 2):249-78. doi:10.1093/brain/124.2.249
7. Maas AI, Menon DK, Lingsma HF, Pineda JA, Sandel ME, Manley GT. Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. J Neurotrauma (2012) 29(1):32-46. doi:10.1089/neu.2010.1599
8. Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O'Connell MT, Czosnyka M, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain (2011) 134(Pt 2):484-94. doi:10.1093/brain/awq353
9. Timofeev I, Czosnyka M, Carpenter KL, Nortje J, Kirkpatrick PJ, Al-Rawi PG, et al. Interaction between brain chemistry and physiology after traumatic brain injury: impact of autoregulation and microdialysis catheter location. J Neurotrauma (2011) 28(6):849-60. doi:10.1089/neu.2010.1656
10. Czosnyka M, Balestreri M, Steiner L, Smielewski P, Hutchinson PJ, Matta B, et al. Age, intracranial pressure, autoregulation, and outcome after brain trauma. J Neurosurg (2005) 102(3):450-4. doi:10.3171/jns.2005.102.3.0450
11. Jalloh I, Helmy A, Shannon RJ, Gallagher CN, Menon DK, Carpenter KL, et al. Lactate uptake by the injured human brain: evidence from an arteriovenous gradient and cerebral microdialysis study. J Neurotrauma (2013) 30(24):2031-7. doi:10.1089/neu.2013.2947
12. Hutchinson PJ, O'Connell MT, Seal A, Nortje J, Timofeev I, Al-Rawi PG, et al. A combined microdialysis and FDG-PET study of glucose metabolism in head injury. Acta Neurochir (Wien) (2009) 151(1):51-61. doi:10.1007/s00701-008-0169-1
13. Hutchinson PJ, Gupta AK, Fryer TF, Al-Rawi PG, Chatfield DA, Coles JP, et al. Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: a combined microdialysis and triple oxygen positron emission tomography study. J Cereb Blood Flow Metab (2002) 22(6):735-45. doi:10.1097/00004647-200206000-00012
14. Folkersma H, Boellaard R, Yaqub M, Kloet RW, Windhorst AD, Lammertsma AA, et al. Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury. J Nucl Med (2011) 52(8):1235-9. doi:10.2967/jnumed.110.084061
15. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol (2011) 70(3):374-83. doi:10.1002/ana.22455
16. Helmy A, De Simoni MG, Guilfoyle MR, Carpenter KL, Hutchinson PJ. Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol (2011) 95(3):352-72. doi:10.1016/j.pneurobio.2011.09.003
17. Marino S, Zei E, Battaglini M, Vittori C, Buscalferri A, Bramanti P, et al. Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. J Neurol Neurosurg Psychiatry (2007) 78(5):501-7. doi:10.1136/jnnp.2006.099796
18. Hamilton G, Allsop JM, Patel N, Forton DM, Thomas HC, O'Sullivan CP, et al. Variations due to analysis technique in intracellular pH measurements in simulated and in vivo 31P MR spectra of the human brain. J Magn Reson Imaging (2006) 23(4):459-64. doi:10.1002/jmri.20524
19. Rothman DL, De Feyter HM, de Graaf RA, Mason GF, Behar KL. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed (2011) 24(8):943-57. doi:10.1002/nbm.1772
20. Jalloh I, Carpenter KL, Grice P, Howe DJ, Mason A, Gallagher CN, et al. Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-13C2 glucose. J Cereb Blood Flow Metab (2015) 35(1):111-20. doi:10.1038/jcbfm.2014.177
21. Gallagher CN, Carpenter KL, Grice P, Howe DJ, Mason A, Timofeev I, et al. The human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study. Brain (2009) 132(Pt 10):2839-49. doi:10.1093/brain/awp202
22. Jalloh I, Carpenter KL, Helmy A, Carpenter TA, Menon DK, Hutchinson PJ. Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings. Metab Brain Dis (2014). doi:10.1007/s11011-014-9628-y
23. Aries MJ, Czosnyka M, Budohoski KP, Steiner LA, Lavinio A, Kolias AG, et al. Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med (2012) 40(8):2456-63. doi:10.1097/CCM.0b013e3182514eb6
24. Howells T, Elf K, Jones PA, Ronne-Engstrom E, Piper I, Nilsson P, et al. Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in patients with brain trauma. J Neurosurg (2005) 102(2):311-7. doi:10.3171/jns.2005.102.2.0311
25. Czosnyka M, Smielewski P, Kirkpatrick P, Laing RJ, Menon D, Pickard JD. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery (1997) 41(1):11-7. doi:10.1097/00006123-199707000-00005
26. Joshi B, Ono M, Brown C, Brady K, Easley RB, Yenokyan G, et al. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg (2012) 114(3):503-10. doi:10.1213/ANE.0b013e31823d292a
27. Mitra S, Czosnyka M, Smielewski P, O'Reilly H, Brady K, Austin T. Heart rate passivity of cerebral tissue oxygenation is associated with predictors of poor outcome in preterm infants. Acta Paediatr (2014) 103(9):e374-82. doi:10.1111/apa.12696
28. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma (2007) 24(Suppl 1):S59-64. doi:10.1089/neu.2007.9987
29. Marmarou A, Anderson RL, Ward JD, Choi SC, Young HF, Eisenberg HM, et al. NINDS Traumatic Coma Data Bank: intracranial pressure monitoring methodology. J Neurosurgery (1991) 75(Suppl):S21-7.
30. Grande PO. The "Lund concept" for the treatment of severe head trauma - physiological principles and clinical application. Intensive Care Med (2006) 32(10):1475-84. doi:10.1007/s00134-006-0294-3
31. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma (2007) 24(Suppl 1):S55-8. doi:10.1089/neu.2007.9988
32. Lazaridis C, DeSantis SM, Smielewski P, Menon DK, Hutchinson P, Pickard JD, et al. Patient-specific thresholds of intracranial pressure in severe traumatic brain injury. J Neurosurg (2014) 120(4):893-900. doi:10.3171/2014.1.JNS131292
33. Santos E, Orakcioglu B, Kentar MM, Diedler J, Uozumi Y, Scholl M, et al. Pressure reactivity index correlates with metabolic dysfunction in a porcine model of intracerebral hemorrhage. Acta Neurochir Suppl (2012) 114:363-7. doi:10.1007/978-3-7091-0956-4_70
34. Diedler J, Karpel-Massler G, Sykora M, Poli S, Sakowitz OW, Veltkamp R, et al. Autoregulation and brain metabolism in the perihematomal region of spontaneous intracerebral hemorrhage: an observational pilot study. J Neurol Sci (2010) 295(1-2):16-22. doi:10.1016/j.jns.2010.05.027
35. Yokobori S, Watanabe A, Matsumoto G, Onda H, Masuno T, Fuse A, et al. Time course of recovery from cerebral vulnerability after severe traumatic brain injury: a microdialysis study. J Trauma (2011) 71(5):1235-40. doi:10.1097/TA.0b013e3182140dd7
36. Stein DM, Lindell A, Murdock KR, Kufera JA, Menaker J, Keledjian K, et al. Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury. J Trauma (2011) 70(5):1096-103. doi:10.1097/TA.0b013e318216930d
37. Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, Bochicchio GV, et al. Association of CSF biomarkers and secondary insults following severe traumatic brain injury. Neurocrit Care (2011) 14(2):200-7. doi:10.1007/s12028-010-9496-1
38. Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH III, Clifton GL, et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation (2010) 7:19. doi:10.1186/1742-2094-7-19
39. Dash PK, Redell JB, Hergenroeder G, Zhao J, Clifton GL, Moore A. Serum ceruloplasmin and copper are early biomarkers for traumatic brain injury-associated elevated intracranial pressure. J Neurosci Res (2010) 88(8):1719-26. doi:10.1002/jnr.22336
40. Hergenroeder G, Redell JB, Moore AN, Dubinsky WP, Funk RT, Crommett J, et al. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma (2008) 25(2):79-93. doi:10.1089/neu.2007.0386
41. Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med (2012) 367(26):2471-81. doi:10.1056/NEJMoa1207363
42. Stocchetti N, Picetti E, Berardino M, Buki A, Chesnut RM, Fountas KN, et al. Clinical applications of intracranial pressure monitoring in traumatic brain injury: report of the Milan consensus conference. Acta Neurochir (Wien) (2014) 156(8):1615-22. doi:10.1007/s00701-014-2127-4
43. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab (2005) 25(6):763-74. doi:10.1038/sj.jcbfm.9600073
44. Kawamata T, Katayama Y, Hovda DA, Yoshino A, Becker DP. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab (1992) 12(1):12-24. doi:10.1038/jcbfm.1992.3
45. Yoshino A, Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res (1991) 561(1):106-19. doi:10.1016/0006-8993(91)90755-K
46. Sunami K, Nakamura T, Ozawa Y, Kubota M, Namba H, Yamaura A. Hypermetabolic state following experimental head injury. Neurosurg Rev (1989) 12(Suppl 1):400-11. doi:10.1007/BF01790682
47. Hattori N, Huang SC, Wu HM, Yeh E, Glenn TC, Vespa PM, et al. Correlation of regional metabolic rates of glucose with Glasgow coma scale after traumatic brain injury. J Nucl Med (2003) 44(11):1709-16.
48. Bergsneider M, Hovda DA, Lee SM, Kelly DF, McArthur DL, Vespa PM, et al. Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury. J Neurotrauma (2000) 17(5):389-401. doi:10.1089/neu.2000.17.389
49. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg (1997) 86(2):241-51. doi:10.3171/jns.1997.86.2.0241
50. Helbok R, Kurtz P, Schmidt JM, Stuart RM, Fernandez L, Malhotra R, et al. Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke. J Neurol Neurosurg Psychiatry (2011) 82(4):378-83. doi:10.1136/jnnp.2009.198754
51. Oddo M, Frangos S, Milby A, Chen I, Maloney-Wilensky E, Murtrie EM, et al. Induced normothermia attenuates cerebral metabolic distress in patients with aneurysmal subarachnoid hemorrhage and refractory fever. Stroke (2009) 40(5):1913-6. doi:10.1161/STROKEAHA.108.534115
52. Ho CL, Wang CM, Lee KK, Ng I, Ang BT. Cerebral oxygenation, vascular reactivity, and neurochemistry following decompressive craniectomy for severe traumatic brain injury. J Neurosurg (2008) 108(5):943-9. doi:10.3171/JNS/2008/108/5/0943
53. Soukup J, Zauner A, Doppenberg EM, Menzel M, Gilman C, Bullock R, et al. Relationship between brain temperature, brain chemistry and oxygen delivery after severe human head injury: the effect of mild hypothermia. Neurol Res (2002) 24(2):161-8. doi:10.1179/016164102101199710
54. Hillered L, Persson L, Ponten U, Ungerstedt U. Neurometabolic monitoring of the ischaemic human brain using microdialysis. Acta Neurochir (Wien) (1990) 102(3-4):91-7. doi:10.1007/BF01405420
55. Persson L, Hillered L. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg (1992) 76(1):72-80. doi:10.3171/jns.1992.76.1.0072
56. Paraforou T, Paterakis K, Fountas K, Paraforos G, Chovas A, Tasiou A, et al. Cerebral perfusion pressure, microdialysis biochemistry and clinical outcome in patients with traumatic brain injury. BMC Res Notes (2011) 4:540. doi:10.1186/1756-0500-4-540
57. Hlatky R, Valadka AB, Goodman JC, Robertson CS. Evolution of brain tissue injury after evacuation of acute traumatic subdural hematomas. Neurosurgery (2004) 55(6):1318-23. doi:10.1227/01.NEU.0000143029.42638.2C
58. Zauner A, Doppenberg EM, Woodward JJ, Choi SC, Young HF, Bullock R. Continuous monitoring of cerebral substrate delivery and clearance: initial experience in 24 patients with severe acute brain injuries. Neurosurgery (1997) 41(5):1082-91. doi:10.1097/00006123-199711000-00011
59. Vespa PM, McArthur D, O'Phelan K, Glenn T, Etchepare M, Kelly D, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab (2003) 23(7):865-77. doi:10.1097/01.WCB.0000076701.45782.EF
60. Meierhans R, Bechir M, Ludwig S, Sommerfeld J, Brandi G, Haberthur C, et al. Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury. Crit Care (2010) 14(1):R13. doi:10.1186/cc8869
61. Oddo M, Levine JM, Frangos S, Maloney-Wilensky E, Carrera E, Daniel RT, et al. Brain lactate metabolism in humans with subarachnoid hemorrhage. Stroke (2012) 43(5):1418-21. doi:10.1161/STROKEAHA.111.648568
62. Clausen T, Khaldi A, Zauner A, Reinert M, Doppenberg E, Menzel M, et al. Cerebral acid-base homeostasis after severe traumatic brain injury. J Neurosurg (2005) 103(4):597-607. doi:10.3171/jns.2005.103.4.0597
63. Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, Pickard JD, Kirkpatrick PJ. Adverse cerebral events detected after subarachnoid hemorrhage using brain oxygen and microdialysis probes. Neurosurgery (2002) 50(6):1213-21. doi:10.1097/00006123-200206000-00008
64. Bouzat P, Sala N, Suys T, Zerlauth JB, Marques-Vidal P, Feihl F, et al. Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain. Intensive Care Med (2014) 40(3):412-21. doi:10.1007/s00134-013-3203-6
65. Sarrafzadeh AS, Haux D, Ludemann L, Amthauer H, Plotkin M, Kuchler I, et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke (2004) 35(3):638-43. doi:10.1161/01.STR.0000116101.66624.F1
66. Chamoun R, Suki D, Gopinath SP, Goodman JC, Robertson C. Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J Neurosurg (2010) 113(3):564-70. doi:10.3171/2009.12.JNS09689
67. Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med (2002) 30(5):1062-70. doi:10.1097/00003246-200205000-00018
68. Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 94(5):740-9. doi:10.3171/jns.2001.94.5.0740
69. Nagel A, Graetz D, Schink T, Frieler K, Sakowitz O, Vajkoczy P, et al. Relevance of intracranial hypertension for cerebral metabolism in aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg (2009) 111(1):94-101. doi:10.3171/2009.1.JNS08587
70. Li AL, Zhi DS, Wang Q, Huang HL. Extracellular glycerol in patients with severe traumatic brain injury. Chin J Traumatol (2008) 11(2):84-8.
71. Peerdeman SM, Girbes AR, Polderman KH, Vandertop WP. Changes in cerebral interstitial glycerol concentration in head-injured patients; correlation with secondary events. Intensive Care Med (2003) 29(10):1825-8. doi:10.1007/s00134-003-1850-8
72. Schmidt JM, Ko SB, Helbok R, Kurtz P, Stuart RM, Presciutti M, et al. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke (2011) 42(5):1351-6. doi:10.1161/STROKEAHA.110.596874
73. Stein NR, McArthur DL, Etchepare M, Vespa PM. Early cerebral metabolic crisis after TBI influences outcome despite adequate hemodynamic resuscitation. Neurocrit Care (2012) 17(1):49-57. doi:10.1007/s12028-012-9708-y
74. Oddo M, Levine JM, Kumar M, Iglesias K, Frangos S, Maloney-Wilensky E, et al. Anemia and brain oxygen after severe traumatic brain injury. Intensive Care Med (2012) 38(9):1497-504. doi:10.1007/s00134-012-2593-1
75. Nelson DW, Thornquist B, MacCallum RM, Nystrom H, Holst A, Rudehill A, et al. Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement. BMC Med (2011) 9:21. doi:10.1186/1741-7015-9-21
76. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech (2003) 60(6):614-32. doi:10.1002/jemt.10303
77. Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol (2011) 93(3):421-43. doi:10.1016/j.pneurobio.2011.01.005
78. Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, et al. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article. J Neurosurg (2013) 118(6):1298-303. doi:10.3171/2013.1.JNS121181
79. Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma (2010) 69(1):104-9. doi:10.1097/TA.0b013e3181bbd485
80. Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock (2002) 18(5):395-400. doi:10.1097/00024382-200211000-00002
81. Fridriksson T, Kini N, Walsh-Kelly C, Hennes H. Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study. Acad Emerg Med (2000) 7(7):816-20. doi:10.1111/j.1553-2712.2000.tb02276.x
82. Helmy A, Timofeev I, Palmer CR, Gore A, Menon DK, Hutchinson PJ. Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury. Acta Neurochir (Wien) (2010) 152(6):953-7. doi:10.1007/s00701-009-0584-y
83. Vespa P, McArthur DL, Stein N, Huang SC, Shao W, Filippou M, et al. Tight glycemic control increases metabolic distress in traumatic brain injury: a randomized controlled within-subjects trial. Crit Care Med (2012) 40(6):1923-9. doi:10.1097/CCM.0b013e31824e0fcc
84. Donnelly J, Czosnyka M, Sudhan N, Varsos GV, Nasr N, Jalloh I, et al. Increased blood glucose is related to disturbed cerebrovascular pressure reactivity after traumatic brain injury. Neurocrit Care (2015) 22(1):20-5. doi:10.1007/s12028-014-0042-4
85. Jauch-Chara K, Oltmanns KM. Glycemic control after brain injury: boon and bane for the brain. Neuroscience (2014) 283:202-9. doi:10.1016/j.neuroscience.2014.04.059
86. Bouzat P, Magistretti PJ, Oddo M. Hypertonic lactate and the injured brain: facts and the potential for positive clinical implications. Intensive Care Med (2014) 40(6):920-1. doi:10.1007/s00134-014-3312-x
87. Nordstrom CH, Nielsen TH. Exogenous lactate supplementation to the injured brain: misleading conclusions with clinical implications. Intensive Care Med (2014) 40(6):919. doi:10.1007/s00134-014-3297-5
88. Mannion RJ, Cross J, Bradley P, Coles JP, Chatfield D, Carpenter A, et al. Mechanism-based MRI classification of traumatic brainstem injury and its relationship to outcome. J Neurotrauma (2007) 24(1):128-35. doi:10.1089/neu.2006.0127
89. Bigler ED. Neuropsychological results and neuropathological findings at autopsy in a case of mild traumatic brain injury. J Int Neuropsychol Soc (2004) 10(5):794-806. doi:10.1017/S1355617704105146
90. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet (1994) 344(8929):1055-6. doi:10.1016/S0140-6736(94)91712-4
91. Moen KG, Skandsen T, Folvik M, Brezova V, Kvistad KA, Rydland J, et al. A longitudinal MRI study of traumatic axonal injury in patients with moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry (2012) 83(12):1193-200. doi:10.1136/jnnp-2012-302644
92. Galanaud D, Perlbarg V, Gupta R, Stevens RD, Sanchez P, Tollard E, et al. Assessment of white matter injury and outcome in severe brain trauma: a prospective multicenter cohort. Anesthesiology (2012) 117(6):1300-10. doi:10.1097/ALN.0b013e3182755558
93. Newcombe VF, Williams GB, Nortje J, Bradley PG, Harding SG, Smielewski P, et al. Analysis of acute traumatic axonal injury using diffusion tensor imaging. Br J Neurosurg (2007) 21(4):340-8. doi:10.1080/02688690701400882
94. Aoki Y, Inokuchi R, Gunshin M, Yahagi N, Suwa H. Diffusion tensor imaging studies of mild traumatic brain injury: a meta-analysis. J Neurol Neurosurg Psychiatry (2012) 83(9):870-6. doi:10.1136/jnnp-2012-302742
95. Newcombe V, Chatfield D, Outtrim J, Vowler S, Manktelow A, Cross J, et al. Mapping traumatic axonal injury using diffusion tensor imaging: correlations with functional outcome. PLoS One (2011) 6(5):e19214. doi:10.1371/journal.pone.0019214
96. Hulkower MB, Poliak DB, Rosenbaum SB, Zimmerman ME, Lipton MLA. Decade of DTI in traumatic brain injury: 10 years and 100 articles later. AJNR Am J Neuroradiol (2013) 34(11):2064-74. doi:10.3174/ajnr.A3395
97. Benson RR, Gattu R, Sewick B, Kou Z, Zakariah N, Cavanaugh JM, et al. Detection of hemorrhagic and axonal pathology in mild traumatic brain injury using advanced MRI: implications for neurorehabilitation. NeuroRehabilitation (2012) 31(3):261-79. doi:10.3233/NRE-2012-0795
98. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging (2005) 22(4):439-50. doi:10.1002/jmri.20404
99. Dinkel J, Drier A, Khalilzadeh O, Perlbarg V, Czernecki V, Gupta R, et al. Long-term white matter changes after severe traumatic brain injury: a 5-year prospective cohort. AJNR Am J Neuroradiol (2013) 35(1):23-9. doi:10.3174/ajnr.A3616
100. Farbota KD, Bendlin BB, Alexander AL, Rowley HA, Dempsey RJ, Johnson SC. Longitudinal diffusion tensor imaging and neuropsychological correlates in traumatic brain injury patients. Front Hum Neurosci (2012) 6:160. doi:10.3389/fnhum.2012.00160
101. Khursheed F, Rohlffs F, Suzuki S, Kim DH, Ellmore TM. Artifact quantification and tractography from 3T MRI after placement of aneurysm clips in subarachnoid hemorrhage patients. BMC Med Imaging (2011) 11:19. doi:10.1186/1471-2342-11-19
102. Jeon SB, Parikh G, Choi HA, Badjatia N, Lee K, Schmidt JM, et al. Cerebral microbleeds in patients with acute subarachnoid hemorrhage. Neurosurgery (2014) 74(2):176-81. doi:10.1227/NEU.0000000000000244
103. Wartenberg KE, Sheth SJ, Michael Schmidt J, Frontera JA, Rincon F, Ostapkovich N, et al. Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage. Neurocrit Care (2011) 14(3):407-15. doi:10.1007/s12028-010-9488-1
104. Sato K, Shimizu H, Fujimura M, Inoue T, Matsumoto Y, Tominaga T. Acute-stage diffusion-weighted magnetic resonance imaging for predicting outcome of poor-grade aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab (2010) 30(6):1110-20. doi:10.1038/jcbfm.2009.264
105. Vatter H, Guresir E, Berkefeld J, Beck J, Raabe A, du Mesnil de Rochemont R, et al. Perfusion-diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2011) 82(8):876-83. doi:10.1136/jnnp.2010.219592
106. Ohtonari T, Kakinuma K, Kito T, Ezuka I, Kanazawa T. Diffusion-perfusion mismatch in symptomatic vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) (2008) 48(8):331-6. doi:10.2176/nmc.48.331
107. Govindaraju V, Gauger GE, Manley GT, Ebel A, Meeker M, Maudsley AA. Volumetric proton spectroscopic imaging of mild traumatic brain injury. AJNR Am J Neuroradiol (2004) 25(5):730-7.
108. Condon B, Oluoch-Olunya D, Hadley D, Teasdale G, Wagstaff A. Early 1H magnetic resonance spectroscopy of acute head injury: four cases. J Neurotrauma (1998) 15(8):563-71. doi:10.1089/neu.1998.15.563
109. Signoretti S, Marmarou A, Aygok GA, Fatouros PP, Portella G, Bullock RM. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy. J Neurosurg (2008) 108(1):42-52. doi:10.3171/JNS/2008/108/01/0042
110. Carpentier A, Galanaud D, Puybasset L, Muller JC, Lescot T, Boch AL, et al. Early morphologic and spectroscopic magnetic resonance in severe traumatic brain injuries can detect "invisible brain stem damage" and predict "vegetative states". J Neurotrauma (2006) 23(5):674-85. doi:10.1089/neu.2006.23.674
111. Uzan M, Albayram S, Dashti SG, Aydin S, Hanci M, Kuday C. Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury. J Neurol Neurosurg Psychiatry (2003) 74(1):33-8. doi:10.1136/jnnp.74.1.33
112. Ricci R, Barbarella G, Musi P, Boldrini P, Trevisan C, Basaglia N. Localised proton MR spectroscopy of brain metabolism changes in vegetative patients. Neuroradiology (1997) 39(5):313-9. doi:10.1007/s002340050415
113. Scheel M, Dreier JP, Bohner G. Evaluation of intracranial electrocorticography recording strips and tissue partial pressure of oxygen and temperature probes for radio-frequency-induced heating. Acta Neurochir Suppl (2013) 115:149-52. doi:10.1007/978-3-7091-1192-5_29
114. Newcombe VF, Hawkes RC, Harding SG, Willcox R, Brock S, Hutchinson PJ, et al. Potential heating caused by intraparenchymal intracranial pressure transducers in a 3-Tesla magnetic resonance imaging system using a body radiofrequency resonator: assessment of the Codman MicroSensor Transducer. J Neurosurg (2008) 109(1):159-64. doi:10.3171/JNS/2008/109/7/0159
115. Coles JP, Steiner LA, Martin J, Donovan T, Hutchinson PJ, Carpenter TA, et al. Assessment of the ventrix parenchymal intracranial pressure monitoring probe (NL950-P) and monitor (NL950-100) in a 3 Tesla magnetic resonance scanner. Anaesthesia (2003) 58(2):143-8. doi:10.1046/j.1365-2044.2003.02966.x
116. Nicholson C, Kamali-Zare P, Tao L. Brain extracellular space as a diffusion barrier. Comput Vis Sci (2011) 14(7):309-25. doi:10.1007/s00791-012-0185-9
117. Sykova E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev (2008) 88(4):1277-340. doi:10.1152/physrev.00027.2007
118. Nicholson C, Sykova E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci (1998) 21(5):207-15. doi:10.1016/S0166-2236(98)01261-2
119. Kirov II, Tal A, Babb JS, Lui YW, Grossman RI, Gonen O. Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study. J Neurol (2013) 260(1):242-52. doi:10.1007/s00415-012-6626-z
120. Puts NA, Edden RA. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2012) 60:29-41. doi:10.1016/j.pnmrs.2011.06.001
121. Kierans AS, Kirov II, Gonen O, Haemer G, Nisenbaum E, Babb JS, et al. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury. Neurology (2014) 82(6):521-8. doi:10.1212/WNL.0000000000000105
122. Signoretti S, Di Pietro V, Vagnozzi R, Lazzarino G, Amorini AM, Belli A, et al. Transient alterations of creatine, creatine phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic brain injury in the rat. Mol Cell Biochem (2010) 333(1-2):269-77. doi:10.1007/s11010-009-0228-9
123. Lei H, Berthet C, Hirt L, Gruetter R. Evolution of the neurochemical profile after transient focal cerebral ischemia in the mouse brain. J Cereb Blood Flow Metab (2009) 29(4):811-9. doi:10.1038/jcbfm.2009.8
124. Maddock RJ, Buonocore MH. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci (2012) 11:199-251. doi:10.1007/7854_2011_197
125. Marino S, Ciurleo R, Bramanti P, Federico A, De Stefano N. 1H-MR spectroscopy in traumatic brain injury. Neurocrit Care (2011) 14(1):127-33. doi:10.1007/s12028-010-9406-6
126. Hochachka PW, Clark CM, Holden JE, Stanley C, Ugurbil K, Menon RS. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci U S A (1996) 93(3):1215-20. doi:10.1073/pnas.93.3.1215
127. Befroy DE, Rothman DL, Petersen KF, Shulman GI. (3)(1)P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism. Diabetes (2012) 61(11):2669-78. doi:10.2337/db12-0558
128. Petroff OA, Prichard JW, Behar KL, Alger JR, den Hollander JA, Shulman RG. Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology (1985) 35(6):781-8. doi:10.1212/WNL.35.6.781
129. McIntosh TK, Faden AI, Bendall MR, Vink R. Traumatic brain injury in the rat: alterations in brain lactate and pH as characterized by 1H and 31P nuclear magnetic resonance. J Neurochem (1987) 49(5):1530-40. doi:10.1111/j.1471-4159.1987.tb01024.x
130. Vink R, McIntosh TK, Weiner MW, Faden AI. Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study. J Cereb Blood Flow Metab (1987) 7(5):563-71. doi:10.1038/jcbfm.1987.106
131. Garnett MR, Corkill RG, Blamire AM, Rajagopalan B, Manners DN, Young JD, et al. Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study. J Neurotrauma (2001) 18(3):231-40. doi:10.1089/08977150151070838
132. Gupta AK, Zygun DA, Johnston AJ, Steiner LA, Al-Rawi PG, Chatfield D, et al. Extracellular brain pH and outcome following severe traumatic brain injury. J Neurotrauma (2004) 21(6):678-84. doi:10.1089/0897715041269722
133. Timofeev I, Nortje J, Al-Rawi PG, Hutchinson PJ, Gupta AK. Extracellular brain pH with or without hypoxia is a marker of profound metabolic derangement and increased mortality after traumatic brain injury. J Cereb Blood Flow Metab (2013) 33(3):422-7. doi:10.1038/jcbfm.2012.186
134. de Graaf RA, Rothman DL, Behar KL. State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed (2011) 24(8):958-72. doi:10.1002/nbm.1761
135. Carpenter KL, Jalloh I, Gallagher CN, Grice P, Howe DJ, Mason A, et al. (13)C-labelled microdialysis studies of cerebral metabolism in TBI patients. Eur J Pharm Sci (2014) 57:87-97. doi:10.1016/j.ejps.2013.12.012
136. Denes A, Thornton P, Rothwell NJ, Allan SM. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun (2010) 24(5):708-23. doi:10.1016/j.bbi.2009.09.010
137. Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock (2004) 22(2):102-7. doi:10.1097/01.shk.0000131193.80038.f1
138. Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock (2005) 23(5):406-10. doi:10.1097/01.shk.0000161385.62758.24
139. Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KL, et al. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma (2007) 24(10):1545-57. doi:10.1089/neu.2007.0295
140. Chiaretti A, Antonelli A, Mastrangelo A, Pezzotti P, Tortorolo L, Tosi F, et al. Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma (2008) 25(3):225-34. doi:10.1089/neu.2007.0405
141. Chiaretti A, Genovese O, Aloe L, Antonelli A, Piastra M, Polidori G, et al. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst (2005) 21(3):185-93. doi:10.1007/s00381-004-1032-1
142. Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, Moulton RJ. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma (2002) 19(8):929-37. doi:10.1089/089771502320317087
143. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol (1999) 101(2):211-21. doi:10.1016/S0165-5728(99)00148-4
144. Goodman JC, Van M, Gopinath SP, Robertson CS. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir Suppl (2008) 102:437-9. doi:10.1007/978-3-211-85578-2_85
145. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab (1997) 17(3):280-9. doi:10.1097/00004647-199703000-00005
146. Kushi H, Saito T, Makino K, Hayashi N. IL-8 is a key mediator of neuroinflammation in severe traumatic brain injuries. Acta Neurochir Suppl (2003) 86:347-50.
147. Gopcevic A, Mazul-Sunko B, Marout J, Sekulic A, Antoljak N, Siranovic M, et al. Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku J Exp Med (2007) 211(4):387-93. doi:10.1620/tjem.211.387
148. Yan J, Greer JM, McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J Neuroimmunol (2012) 246(1-2):78-84. doi:10.1016/j.jneuroim.2012.02.013
149. An SA, Kim J, Kim OJ, Kim JK, Kim NK, Song J, et al. Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke. Clin Biochem (2013) 46(9):710-5. doi:10.1016/j.clinbiochem.2013.02.005
150. Pinteaux E, Trotter P, Simi A. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine (2009) 45(1):1-7. doi:10.1016/j.cyto.2008.10.008
151. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab (2009) 29(3):464-79. doi:10.1038/jcbfm.2008.141
152. Kadhim HJ, Duchateau J, Sebire G. Cytokines and brain injury: invited review. J Intensive Care Med (2008) 23(4):236-49. doi:10.1177/0885066608318458
153. Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci (2008) 9(6):481-93. doi:10.1038/nrn2398
154. Viviani B, Bartesaghi S, Corsini E, Galli CL, Marinovich M. Cytokines role in neurodegenerative events. Toxicol Lett (2004) 149(1-3):85-9. doi:10.1016/j.toxlet.2003.12.022
155. Helmy A, Antoniades CA, Guilfoyle MR, Carpenter KL, Hutchinson PJ. Principal component analysis of the cytokine and chemokine response to human traumatic brain injury. PLoS One (2012) 7(6):e39677. doi:10.1371/journal.pone.0039677
156. Uzan M, Erman H, Tanriverdi T, Sanus GZ, Kafadar A, Uzun H. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury. Acta Neurochir (Wien) (2006) 148(11):1157-64. doi:10.1007/s00701-006-0887-1
157. Hentze H, Schwoebel F, Lund S, Keel M, Ertel W, Wendel A, et al. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun (2001) 283(5):1111-7. doi:10.1006/bbrc.2001.4918
158. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. J Neuroimmunol (2002) 122(1-2):167-74. doi:10.1016/S0165-5728(01)00466-0
159. Au AK, Aneja RK, Bell MJ, Bayir H, Feldman K, Adelson PD, et al. Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. J Neurotrauma (2012) 29(11):2013-21. doi:10.1089/neu.2011.2171
160. Wagner AK, Amin KB, Niyonkuru C, Postal BA, McCullough EH, Ozawa H, et al. CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J Cereb Blood Flow Metab (2011) 31(9):1886-96. doi:10.1038/jcbfm.2011.31
161. Darwish RS, Amiridze NS. Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury. Neurocrit Care (2010) 12(3):337-41. doi:10.1007/s12028-009-9328-3
162. Clark RS, Kochanek PM, Adelson PD, Bell MJ, Carcillo JA, Chen M, et al. Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. J Pediatr (2000) 137(2):197-204. doi:10.1067/mpd.2000.106903
163. Mondello S, Robicsek SA, Gabrielli A, Brophy GM, Papa L, Tepas J, et al. AlphaII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J Neurotrauma (2010) 27(7):1203-13. doi:10.1089/neu.2010.1278
164. Petzold A, Tisdall MM, Girbes AR, Martinian L, Thom M, Kitchen N, et al. In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study. Brain (2011) 134(Pt 2):464-83. doi:10.1093/brain/awq360
165. Bell CW, Jiang W, Reich CF III, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol (2006) 291(6):C1318-25. doi:10.1152/ajpcell.00616.2005
166. Satchell MA, Lai Y, Kochanek PM, Wisniewski SR, Fink EL, Siedberg NA, et al. Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J Cereb Blood Flow Metab (2005) 25(7):919-27. doi:10.1038/sj.jcbfm.9600088
167. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology (2010) 74(19):1494-501. doi:10.1212/WNL.0b013e3181dd42b3
168. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg. (1990) 73(1):18-36.
169. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The international cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg (1990) 73(1):37-47. doi:10.3171/jns.1990.73.1.0037
170. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery (1988) 22(4):654-61. doi:10.1227/00006123-198804000-00006
171. Voldby B, Enevoldsen EM. Intracranial pressure changes following aneurysm rupture. Part 1: clinical and angiographic correlations. J Neurosurg (1982) 56(2):186-96. doi:10.3171/jns.1982.56.2.0186
172. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg (1968) 28(1):14-20. doi:10.3171/jns.1968.28.1.0014
173. Drake CG, Hunt WE, Kassell N, Pertuiset B, Sano K, Teasdale G, et al. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg (1988) 68(6):985-6.
174. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery (1980) 6(1):1-9. doi:10.1227/00006123-198001000-00001
175. Abla AA, Wilson DA, Williamson RW, Nakaji P, McDougall CG, Zabramski JM, et al. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial. J Neurosurg (2014) 120(2):391-7. doi:10.3171/2013.10.JNS13419
176. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 59(1):21-7. doi:10.1227/01.NEU.0000218821.34014.1B
177. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke (1988) 19(10):1250-6. doi:10.1161/01.STR.19.10.1250
178. Cremers CH, van der Schaaf IC, Wensink E, Greving JP, Rinkel GJ, Velthuis BK, et al. CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2014) 34(2):200-7. doi:10.1038/jcbfm.2013.208
179. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 33(5):1225-32. doi:10.1161/01.STR.0000015624.29071.1F
180. Helbok R, Ko SB, Schmidt JM, Kurtz P, Fernandez L, Choi HA, et al. Global cerebral edema and brain metabolism after subarachnoid hemorrhage. Stroke (2011) 42(6):1534-9. doi:10.1161/STROKEAHA.110.604488
181. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien) (1988) 42:81-4.
182. Aaslid R, Huber P, Nornes H. A transcranial Doppler method in the evaluation of cerebrovascular spasm. Neuroradiology (1986) 28(1):11-6. doi:10.1007/BF00341759
183. Ramakrishna R, Stiefel M, Udoetuk J, Spiotta A, Levine JM, Kofke WA, et al. Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg (2008) 109(6):1075-82. doi:10.3171/JNS.2008.109.12.1075
184. Chen HI, Stiefel MF, Oddo M, Milby AH, Maloney-Wilensky E, Frangos S, et al. Detection of cerebral compromise with multimodality monitoring in patients with subarachnoid hemorrhage. Neurosurgery (2011) 69(1):53-63. doi:10.1227/NEU.0b013e3182191451
185. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain (2006) 129(Pt 12):3224-37. doi:10.1093/brain/awl297
186. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain (2009) 132(Pt 7):1866-81. doi:10.1093/brain/awp102
187. Ulrich CT, Fung C, Vatter H, Setzer M, Gueresir E, Seifert V, et al. Occurrence of vasospasm and infarction in relation to a focal monitoring sensor in patients after SAH: placing a bet when placing a probe? PLoS One (2013) 8(5):e62754. doi:10.1371/journal.pone.0062754
188. Harper AM, Deshmukh VD, Sengupta D, Rowan JO, Jennett WB. The effect of experimental spasm on the CO2 response of cerebral bloodflow in primates. Neuroradiology (1972) 3(3):134-6. doi:10.1007/BF00341495
189. Budohoski KP, Czosnyka M, Smielewski P, Kasprowicz M, Helmy A, Bulters D, et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study. Stroke (2012) 43(12):3230-7. doi:10.1161/STROKEAHA.112.669788
190. Jaeger M, Soehle M, Schuhmann MU, Meixensberger J. Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke (2012) 43(8):2097-101. doi:10.1161/STROKEAHA.112.659888
191. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol (1985) 17(2):137-40. doi:10.1002/ana.410170206
192. Sanchez-Pena P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med (2008) 36(8):2267-73. doi:10.1097/CCM.0b013e3181809750
193. Turck N, Vutskits L, Sanchez-Pena P, Robin X, Hainard A, Gex-Fabry M, et al. A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med (2010) 36(1):107-15. doi:10.1007/s00134-009-1641-y
194. Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg (2000) 92(3):390-400. doi:10.3171/jns.2000.92.3.0390
195. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 10(7):618-25. doi:10.1016/S1474-4422(11)70108-9
196. Muroi C, Hugelshofer M, Seule M, Tastan I, Fujioka M, Mishima K, et al. Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery (2013) 72(3):367-75. doi:10.1227/NEU.0b013e31828048ce
197. Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery (2007) 60(5):828-36. doi:10.1227/01.NEU.0000255440.21495.80
198. Cho S, Grazioso R, Zhang N, Aykac M, Schmand M. Digital timing: sampling frequency, anti-aliasing filter and signal interpolation filter dependence on timing resolution. Phys Med Biol (2011) 56(23):7569-83. doi:10.1088/0031-9155/56/23/015
199. Rogers ML, Feuerstein D, Leong CL, Takagaki M, Niu X, Graf R, et al. Continuous online microdialysis using microfluidic sensors: dynamic neurometabolic changes during spreading depolarization. ACS Chem Neurosci (2013) 4(5):799-807. doi:10.1021/cn400047x
200. Kanamori K, Ross BD. Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain. Brain Res (2011) 1371:180-91. doi:10.1016/j.brainres.2010.11.064